Progress in Neurobiology, Год журнала: 2020, Номер 199, С. 101963 - 101963
Опубликована: Ноя. 26, 2020
Язык: Английский
Progress in Neurobiology, Год журнала: 2020, Номер 199, С. 101963 - 101963
Опубликована: Ноя. 26, 2020
Язык: Английский
Fluids and Barriers of the CNS, Год журнала: 2020, Номер 17(1)
Опубликована: Июль 22, 2020
Abstract Receptor-mediated transcytosis (RMT) is a principal pathway for transport of macromolecules essential brain function across the blood–brain barrier (BBB). Antibodies or peptide ligands which bind RMT receptors are often co-opted delivery biotherapeutics. Constitutively recycling transferrin receptor (TfR) prototype utilized to shuttle therapeutic cargos BBB. Several other BBB-expressed have been shown mediate antibodies protein including insulin (INSR) and insulin-like growth factor-1 (IGF1R), lipid transporters LRP1, LDLR, LRP8 TMEM30A, solute carrier family transporter SLC3A2/CD98hc leptin (LEPR). In this study, we analyzed expression patterns genes encoding in isolated microvessels, parenchyma peripheral organs mouse human using RNA-seq approach. IGF1R, INSR were highly enriched microvessels compared tissues. only was either lung. The levels SLC2A1, TFRC significantly higher microvessels. these by Western blot immunofluorescent staining correlated with their transcript abundance. This study provides molecular transcriptomics map key tissues, important translational studies biodistribution, efficacy safety developed against receptors.
Язык: Английский
Процитировано
129Neuron, Год журнала: 2019, Номер 103(5), С. 771 - 783
Опубликована: Сен. 1, 2019
Язык: Английский
Процитировано
115Biochemical Pharmacology, Год журнала: 2020, Номер 180, С. 114187 - 114187
Опубликована: Авг. 2, 2020
Язык: Английский
Процитировано
108ACS Applied Materials & Interfaces, Год журнала: 2019, Номер 11(37), С. 33637 - 33649
Опубликована: Авг. 21, 2019
There is a dire need to develop more effective therapeutics combat brain cancer such as glioblastoma multiforme (GBM). An ideal treatment expected target deliver chemotherapeutics glioma cells across the blood-brain barrier (BBB). The overexpression of transferrin (Tf) receptor (TfR) on BBB and GBM cell surfaces but not surrounding renders TfR promising target. While porous silicon nanoparticles (pSiNPs) have been intensely studied delivery vehicle due their high biocompatibility, degradability, drug-loading capacity, potential drugs with (Tf)-functionalized pSiNPs remains unaddressed. Here, we developed systematically evaluated Tf-functionalized (Tf@pSiNPs) glioma-targeted drug system. These showed excellent colloidal stability had low toxicity profile. As compared nontargeted pSiNPs, Tf@pSiNPs were selective BBB-forming efficiently internalized through clathrin receptor-mediated endocytosis. anticancer doxorubicin (Dox) was effectively loaded (8.8 wt %) released from in pH-responsive manner over 24 h. Furthermore, results demonstrate that Dox delivered by induced significantly enhanced cytotoxicity an vitro monolayer free Dox. Overall, offer toolbox for enabling targeted therapy treat GBM.
Язык: Английский
Процитировано
104Progress in Neurobiology, Год журнала: 2020, Номер 199, С. 101963 - 101963
Опубликована: Ноя. 26, 2020
Язык: Английский
Процитировано
102